Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A
Mol Cancer. 2025; 24(1):58.
PMID: 40011944
PMC: 11863469.
DOI: 10.1186/s12943-025-02267-0.
Kim K, Lew R, Higashihara T, Yamashita S, Pang M, Stafford M
Surg Neurol Int. 2025; 15():459.
PMID: 39777174
PMC: 11704430.
DOI: 10.25259/SNI_190_2024.
Xue J, Zhang J, Zhu J
Discov Oncol. 2024; 15(1):743.
PMID: 39630160
PMC: 11618281.
DOI: 10.1007/s12672-024-01649-y.
Manescu Paltanea V, Antoniac I, Paltanea G, Nemoianu I, Mohan A, Antoniac A
Int J Mol Sci. 2024; 25(18).
PMID: 39337552
PMC: 11432100.
DOI: 10.3390/ijms251810065.
Siri S, Burchett A, Datta M
Biomech Model Mechanobiol. 2024; 23(6):2229-2241.
PMID: 39298038
PMC: 11554883.
DOI: 10.1007/s10237-024-01890-y.
A nomogram with Ki-67 in the prediction of postoperative recurrence and death for glioma.
Li F, Wang D, Wang N, Wu L, Yu B
Sci Rep. 2024; 14(1):20334.
PMID: 39223159
PMC: 11368915.
DOI: 10.1038/s41598-024-71275-9.
VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells.
Tian Y, Gao X, Yang X, Chen S, Ren Y
BMC Cancer. 2024; 24(1):1040.
PMID: 39174921
PMC: 11342494.
DOI: 10.1186/s12885-024-12803-8.
An updated and comprehensive review of the morphology, ethnomedicinal uses, phytochemistry, and pharmacological activity of L. f.
Fan X, Qin Z, Wen J, Wang Z, Xiao W
Heliyon. 2024; 10(15):e35267.
PMID: 39166058
PMC: 11334675.
DOI: 10.1016/j.heliyon.2024.e35267.
Survival analysis and associated factors of highgrade glioma patients.
Barrera L, Ortiz L, Grisales H, Camargo M
Biomedica. 2024; 44(2):191-206.
PMID: 39088535
PMC: 11374120.
DOI: 10.7705/biomedica.6742.
Liquid Biopsy in Whole Blood for Identification of Gene Expression Patterns (mRNA and miRNA) Associated with Recurrence of Glioblastoma WHO CNS Grade 4.
Muhtadi R, Bernhardt D, Multhoff G, Honikl L, Combs S, Krieg S
Cancers (Basel). 2024; 16(13).
PMID: 39001407
PMC: 11240769.
DOI: 10.3390/cancers16132345.
Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors.
Buccarelli M, Castellani G, Fiorentino V, Pizzimenti C, Beninati S, Ricci-Vitiani L
Cells. 2024; 13(8.
PMID: 38667282
PMC: 11048792.
DOI: 10.3390/cells13080667.
Current state of research on copper complexes in the treatment of breast cancer.
Hu K, Guo J, Zeng J, Shao Y, Wu B, Mo J
Open Life Sci. 2024; 19(1):20220840.
PMID: 38585632
PMC: 10997149.
DOI: 10.1515/biol-2022-0840.
RETROSPECTIVE EVALUATION OF MRI PATTERN OF GLIOBLASTOMA IN A TERTIARY HOSPITAL IN NIGERIA.
Ogbole G, Ogunleye O, Nweke M, Akinmoladun J
Ann Ib Postgrad Med. 2024; 21(2):17-23.
PMID: 38298333
PMC: 10811701.
Investigating the Association between the Autophagy Markers LC3B, , and DRAM and Autophagy-Related Genes in Glioma.
Danish F, Qureshi M, Mirza T, Amin W, Sufiyan S, Naeem S
Int J Mol Sci. 2024; 25(1).
PMID: 38203743
PMC: 10779014.
DOI: 10.3390/ijms25010572.
Comparative Analysis of Amino Acid Profiles in Patients with Glioblastoma and Meningioma Using Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS).
Koslinski P, Pluskota R, Koba M, Siedlecki Z, Sniegocki M
Molecules. 2023; 28(23).
PMID: 38067430
PMC: 10707850.
DOI: 10.3390/molecules28237699.
Novel immune checkpoint-related gene model to predict prognosis and treatment responsiveness in low-grade gliomas.
Guo Y, Bao J, Lin D, Hong K, Cen K, Sun J
Heliyon. 2023; 9(9):e20178.
PMID: 37809899
PMC: 10559968.
DOI: 10.1016/j.heliyon.2023.e20178.
Advances in the relationship between temporal muscle thickness and prognosis of patients with glioblastoma: a narrative review.
Tang J, Dong Z, Sheng J, Yang P, Zhao W, Xue J
Front Oncol. 2023; 13:1251662.
PMID: 37771443
PMC: 10525700.
DOI: 10.3389/fonc.2023.1251662.
Personalised therapeutic approaches to glioblastoma: A systematic review.
Mowforth O, Brannigan J, El Khoury M, Partha Sarathi C, Bestwick H, Bhatti F
Front Med (Lausanne). 2023; 10:1166104.
PMID: 37122327
PMC: 10140534.
DOI: 10.3389/fmed.2023.1166104.
Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data.
Schnoller L, Piehlmaier D, Weber P, Brix N, Fleischmann D, Nieto A
Radiat Oncol. 2023; 18(1):51.
PMID: 36906590
PMC: 10007763.
DOI: 10.1186/s13014-023-02241-4.
Cystic Glioblastoma: A Mimicker of Infection? A Case Report and Literature Review.
Thirugnanasambandam R, Silva G, Wu A, Kim C, Cimpeanu E, Minkowitz J
Case Rep Oncol Med. 2023; 2023:7348188.
PMID: 36704640
PMC: 9873443.
DOI: 10.1155/2023/7348188.